| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 42.28B | 30.85B | 28.02B | 27.08B | 37.50B |
| Gross Profit | 35.76B | 21.02B | 17.22B | 12.35B | 21.20B |
| EBITDA | 19.50B | 17.84B | 17.91B | 17.63B | 21.00B |
| Net Income | 9.20B | 7.22B | 7.03B | 7.52B | 10.24B |
Balance Sheet | |||||
| Total Assets | 677.11B | 566.42B | 522.75B | 509.21B | 452.79B |
| Cash, Cash Equivalents and Short-Term Investments | 324.92B | 327.88B | 329.95B | 312.98B | 256.58B |
| Total Debt | 364.85B | 168.50B | 142.52B | 124.45B | 125.39B |
| Total Liabilities | 594.06B | 459.90B | 425.23B | 415.91B | 372.79B |
| Stockholders Equity | 82.99B | 106.47B | 97.48B | 93.25B | 79.82B |
Cash Flow | |||||
| Free Cash Flow | -12.67B | 526.03M | -11.20B | 23.73B | 10.50B |
| Operating Cash Flow | -12.15B | 1.06B | -10.13B | 24.28B | 11.12B |
| Investing Cash Flow | -18.55B | -13.32B | -2.65B | -21.24B | 1.80B |
| Financing Cash Flow | 19.96B | 22.63B | 10.84B | 134.81M | 12.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$139.65B | 10.56 | 8.83% | 0.97% | 64.00% | 112.84% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
59 Neutral | HK$416.52B | 12.45 | 10.28% | 2.05% | 62.72% | 29.18% | |
59 Neutral | HK$148.64B | 9.05 | 9.55% | 3.83% | 51.04% | 24.56% | |
58 Neutral | HK$309.20B | 8.69 | 8.71% | 2.75% | 52.67% | 121.43% | |
57 Neutral | HK$171.64B | 9.77 | 8.46% | 2.92% | 10.82% | 55.25% | |
53 Neutral | HK$168.58B | 9.66 | 10.70% | 2.80% | 36.57% | 77.14% |